R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

This week in clinical trials: 15th-19th January 2024

Continuing our clinical trials updates of 2024, in this instalment we look back at developments in life sciences research and development announced during the week of 15th to 19th January,

R&D

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

R&D

A clearer harmony and attractiveness for EU Clinical Trials ...

EU Clinical Trials Regulation (EU CTR) has been a hot topic for a little while now.

R&D

Changing Faces: Pharma and biotech hires from January 2024

It’s a new year, so we’re kicking it off with the relaunch of Changing Faces after we lost the thread a bit last year.

R&D

JP Morgan 2024 – Katherine Stueland

Diagnostics can be a neglected part of the treatment paradigm, but it’s hugely important for connecting patients with the right treatments.

R&D

Making connections and getting noticed as a biotech start-up...

A thriving start-up ecosystem is essential to the health of the modern life sciences industry, as it provides an incubator for innovative ideas that might be too high-risk for larger, more